Showing results (1691-1700 of 2,464) with videos related to

Sort By:
Pageof 247
Purinergic Signalling|July 29, 2020
Design and in vivo activity of A3 adenosine receptor agonist prodrugsR Rama Suresh, Shanu Jain, Zhoumou Chen, et al.
Nucleosides & Nucleotides|August 26, 1998
A functional screening of adenosine analogues at the adenosine A2B receptor: a search for potent agonistsM de Zwart, R Link, J K von Frijtag Drabbe Künzel, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 19, 2024
Cost-Effectiveness of Axicabtagene Ciloleucel for Adult Patients With Relapsed or Refractory Follicular Lymphoma in the United StatesOlalekan O Oluwole, Markqayne D Ray, Katherine L Rosettie, et al.
Plant Physiology|December 3, 2015
Grapevine Plasticity in Response to an Altered Microclimate: Sauvignon Blanc Modulates Specific Metabolites in Response to Increased Berry ExposurePhilip R Young, Hans A Eyeghe-Bickong, Kari du Plessis, et al.
The Journal of Biological Chemistry|May 5, 2005
Pronounced conformational changes following agonist activation of the M(3) muscarinic acetylcholine receptorSung-Jun Han, Fadi F Hamdan, Soo-Kyung Kim, et al.
Neurochemistry International|April 27, 2013
Dopamine D(2) receptor-mediated modulation of adenosine A(2A) receptor agonist binding within the A(2A)R/D(2)R oligomer frameworkVíctor Fernández-Dueñas, Maricel Gómez-Soler, Xavier Morató, et al.
Journal of Medicinal Chemistry|December 22, 2005
Human P2Y(6) receptor: molecular modeling leads to the rational design of a novel agonist based on a unique conformational preferenceStefano Costanzi, Bhalchandra V Joshi, Savitri Maddileti, et al.
Journal of Medicinal Chemistry|June 8, 2000
Methanocarba analogues of purine nucleosides as potent and selective adenosine receptor agonistsK A Jacobson, X Ji, A H Li, et al.
Cells|December 19, 2019
Adenosine A1-A2A Receptor-Receptor Interaction: Contribution to Guanosine-Mediated EffectsDébora Lanznaster, Caio M Massari, Vendula Marková, et al.
Journal of Medicinal Chemistry|July 21, 2001
Structure-activity relationships of pyridoxal phosphate derivatives as potent and selective antagonists of P2X1 receptorsY C Kim, S G Brown, T K Harden, et al.
Pageof 247